Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.26 trillion and total revenue of $117.15 billion.
Market Cap
1.26T
Revenue
117.15B
Profits
-35.3B
PE Ratio
n/a
Profit Margin
-30.13%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.70B | -0.35% | 247,250 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.95B | 0.37% | 214,926 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 78.75B | -0.80% | 10,472,602 | 2.23B |
| 4 | ARGX | argenx SE | 54.70B | 0.25% | 141,788 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 41.28B | -2.11% | 330,883 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 39.91B | 1.25% | 542,941 | - |
| 7 | RPRX | Royalty Pharma plc | 37.40B | 0.43% | 882,687 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.13B | -1.08% | 561,760 | 4.80B |
| 9 | GMAB | Genmab A/S | 26.49B | -0.01% | 2,359,356 | 4.13B |
| 10 | ROIV | Roivant Sciences Ltd. | 26.36B | 1.25% | 3,849,715 | 7.53M |
| 11 | INCY | Incyte Corporation | 23.53B | 2.44% | 634,172 | 5.82B |
| 12 | BNTX | BioNTech SE | 21.75B | -0.33% | 561,035 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.58B | 0.96% | 1,467,874 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 16.16B | 0.17% | 418,529 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 16.11B | 0.05% | 163,344 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.53B | 0.01% | 461,922 | 1.66B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.54B | 1.65% | 778,821 | 713.07M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 13.41B | 0.42% | 155,652 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.16B | 4.83% | 2,872,808 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | -0.03% | 1,286,516 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.78B | -0.09% | 645,395 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.23B | 1.17% | 69,803 | 1.28B |
| 23 | TWST | Twist Bioscience Corporation | 9.86B | 8.28% | 840,737 | 431.80M |
| 24 | KYMR | Kymera Therapeutics, Inc. | 9.80B | 2.63% | 275,553 | 105.00M |
| 25 | PCVX | Vaxcyte, Inc. | 9.51B | 0.78% | 692,225 | - |
| 26 | CORT | Corcept Therapeutics Incorporated | 9.42B | -0.03% | 321,811 | 830.81M |
| 27 | CAI | Caris Life Sciences, Inc. | 9.40B | 2.48% | 1,677,888 | 989.61M |
| 28 | KRYS | Krystal Biotech, Inc. | 9.35B | 0.74% | 57,107 | 440.48M |
| 29 | SYRE | Spyre Therapeutics, Inc. | 9.10B | 4.83% | 321,671 | - |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.08B | 0.02% | 122,765 | 281.99M |
| 31 | IBRX | ImmunityBio, Inc. | 9.00B | 8.77% | 5,542,893 | 165.79M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.48B | 0.46% | 340,376 | 67.67M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.45B | 1.42% | 712,600 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.95B | 2.26% | 532,798 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.82B | 2.83% | 365,647 | 5.33M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.49B | 0.36% | 97,174 | 7.46M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.28% | 398,552 | 776.57M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.25B | 0.53% | 315,507 | 874.09M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.60B | 5.70% | 5,119,344 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.33B | 2.68% | 85,947 | 239.92M |
| 41 | ORKA | Oruka Therapeutics, Inc. | 6.29B | 5.21% | 635,940 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.22B | 1.25% | 39,037 | 290.54M |
| 43 | IMVT | Immunovant, Inc. | 5.94B | 2.02% | 245,565 | - |
| 44 | BLTE | Belite Bio, Inc | 5.78B | 0.13% | 81,185 | - |
| 45 | MANE | Veradermics, Incorporated | 5.78B | 0.62% | 143,448 | - |
| 46 | KOD | Kodiak Sciences Inc. | 5.73B | 1.96% | 416,731 | - |
| 47 | CGON | CG Oncology, Inc. | 5.66B | 3.74% | 146,447 | 6.23M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.54B | 3.24% | 575,160 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.45B | 0.84% | 249,198 | 618.07M |
| 50 | ERAS | Erasca, Inc. | 5.30B | 1.00% | 1,728,007 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.18B | 1.92% | 250,151 | - |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.07B | -0.62% | 331,889 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.01B | 4.48% | 454,697 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 4.91B | 3.55% | 409,513 | 13.39M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.72B | 0.26% | 682,145 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | 0.26% | 285,710 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.31B | 1.23% | 222,563 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.10B | 3.20% | 887,008 | 10.35M |
| 59 | ABCL | AbCellera Biologics Inc. | 4.09B | 4.39% | 1,716,129 | 66.17M |
| 60 | LEGN | Legend Biotech Corporation | 4.08B | 3.29% | 899,843 | 1.27B |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.97B | -0.79% | 485,304 | 463.98M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.79B | 1.24% | 1,146,514 | 53.81M |
| 63 | IRON | Disc Medicine, Inc. | 3.54B | 2.63% | 379,580 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.49B | 0.88% | 386,171 | 7.50M |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.49B | 2.51% | 514,596 | 1.14B |
| 66 | CELC | Celcuity Inc. | 3.30B | 2.39% | 329,554 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.29B | 6.27% | 511,364 | 148.00K |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.23B | 1.67% | 117,699 | 234.13M |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.21B | 5.64% | 703,011 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | 2.21% | 90,830 | 606.33M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.13B | 6.74% | 885,345 | - |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.07B | 0.50% | 106,357 | 890.79M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.06B | 2.68% | 498,861 | 3.60M |
| 74 | NRIX | Nurix Therapeutics, Inc. | 2.88B | 3.01% | 888,104 | 701.94M |
| 75 | VKTX | Viking Therapeutics, Inc. | 2.86B | 1.20% | 1,564,586 | - |
| 76 | VRDN | Viridian Therapeutics, Inc. | 2.70B | 2.06% | 905,757 | 71.13M |
| 77 | ZLAB | Zai Lab Limited | 2.62B | -3.99% | 710,210 | 449.61M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.54B | 0.90% | 783,938 | 117.00M |
| 79 | MBX | MBX Biosciences, Inc. | 2.52B | 4.20% | 78,236 | - |
| 80 | BEAM | Beam Therapeutics Inc. | 2.50B | 5.21% | 732,596 | 156.04M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.47B | -0.32% | 521,957 | 512.28M |
| 82 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 4.86% | 978,149 | 7.12M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.42B | 6.58% | 11,701,023 | 54.86M |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.39B | 4.50% | 2,467,495 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 1.66% | 219,903 | 158.00K |
| 86 | FTRE | Fortrea Holdings Inc. | 2.31B | 1.80% | 759,506 | 2.68B |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.28B | 0.53% | 163,824 | 311.51M |
| 88 | BHVN | Biohaven Ltd. | 2.27B | 3.81% | 872,422 | - |
| 89 | PHVS | Pharvaris N.V. | 2.26B | 2.28% | 36,789 | - |
| 90 | XNCR | Xencor, Inc. | 2.23B | 2.67% | 895,693 | 104.97M |
| 91 | VCEL | Vericel Corporation | 2.22B | 0.85% | 132,843 | 306.30M |
| 92 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 0.98% | 190,813 | 98.34M |
| 93 | PGEN | Precigen, Inc. | 2.20B | 1.82% | 1,578,913 | 85.72M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | 2.23% | 222,650 | 959.90M |
| 95 | VERA | Vera Therapeutics, Inc. | 2.14B | 4.95% | 328,214 | - |
| 96 | IMNM | Immunome, Inc. | 2.13B | 4.89% | 503,024 | 4.02M |
| 97 | ADRX | ADARx Pharmaceuticals, Inc. | 2.09B | 4.58% | 111,770 | 6.13M |
| 98 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.07B | 5.15% | 768,347 | 208.78M |
| 99 | ZYME | Zymeworks Inc. | 2.03B | 0.99% | 236,053 | 37.13M |
| 100 | LKFT | Lakefront Biotherapeutics NV | 2.01B | -0.52% | 101,677 | 1.13B |
| 101 | SEPN | Septerna, Inc. | 2.00B | 3.31% | 53,595 | 98.88M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | 3.17% | 726,256 | 1.97B |
| 103 | VIR | Vir Biotechnology, Inc. | 1.89B | 1.09% | 523,522 | 303.23M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.89B | 5.92% | 649,962 | - |
| 105 | PVLA | Palvella Therapeutics, Inc. | 1.88B | 3.63% | 50,003 | - |
| 106 | MLYS | Mineralys Therapeutics, Inc. | 1.83B | 0.83% | 1,926,610 | - |
| 107 | ABSI | Absci Corporation | 1.80B | 11.06% | 2,407,154 | 1.56M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.79B | 0.99% | 114,179 | 1.00M |
| 109 | BRVE | Braveheart Bio, Inc. | 1.78B | -0.07% | 44,854 | - |
| 110 | MESO | Mesoblast Limited | 1.78B | 5.49% | 91,661 | 120.25M |
| 111 | MAZE | Maze Therapeutics, Inc. | 1.74B | 0.90% | 110,185 | 20.00M |
| 112 | COAG | Hemab Therapeutics Holdings, Inc. | 1.73B | 3.01% | 103,154 | - |
| 113 | KLRA | Kailera Therapeutics, Inc. | 1.70B | 2.58% | 264,665 | - |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.70B | 3.26% | 456,005 | 27.59M |
| 115 | NBTX | Nanobiotix S.A. | 1.69B | 5.49% | 78,678 | 13.15M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.67B | 5.67% | 224,783 | 26.48M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 4.93% | 1,475,911 | 59.51M |
| 118 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | 4.42% | 1,294,164 | 717.00M |
| 119 | URGN | UroGen Pharma Ltd. | 1.65B | -1.00% | 617,090 | 188.73M |
| 120 | IMCR | Immunocore Holdings plc | 1.63B | 1.37% | 104,166 | 430.78M |
| 121 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 3.73% | 272,704 | - |
| 122 | NVAX | Novavax, Inc. | 1.60B | 3.30% | 2,992,356 | 413.80M |
| 123 | QURE | uniQure N.V. | 1.60B | 6.33% | 475,255 | 18.67M |
| 124 | NUVB | Nuvation Bio Inc. | 1.57B | -0.67% | 1,636,253 | 169.90M |
| 125 | GPCR | Structure Therapeutics Inc. | 1.55B | 3.34% | 271,821 | - |
| 126 | INVA | Innoviva, Inc. | 1.51B | -0.76% | 150,612 | 440.00M |
| 127 | ANAB | AnaptysBio, Inc. | 1.47B | 1.13% | 147,427 | 106.09M |
| 128 | LYCA | Lycia Therapeutics, Inc. | 1.47B | -7.14% | 186,066 | 4.44M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.46B | 3.82% | 165,216 | - |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.24% | 786,830 | 52.06M |
| 131 | KRSA | Korsana Biosciences, Inc. | 1.43B | -2.20% | 81,010 | - |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.43B | 9.47% | 135,532 | 1.30M |
| 133 | GHRS | GH Research PLC | 1.38B | 4.64% | 61,792 | - |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | 3.12% | 1,068,068 | 5.49M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.34B | 2.16% | 74,285 | - |
| 136 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 8.88% | 231,584 | 20.00M |
| 137 | NKTR | Nektar Therapeutics | 1.31B | 2.30% | 119,796 | 54.59M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.28B | 0.92% | 100,697 | - |
| 139 | KARD | Kardigan, Inc. | 1.25B | 5.78% | 167,517 | - |
| 140 | AAPG | Ascentage Pharma Group International | 1.24B | -5.05% | 5,982 | 94.61M |
| 141 | OMER | Omeros Corporation | 1.24B | 4.88% | 326,512 | 38.42M |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.23B | 3.18% | 107,619 | - |
| 143 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 3.18% | 1,029,047 | 252.25M |
| 144 | SVRA | Savara Inc. | 1.21B | 5.53% | 840,193 | - |
| 145 | REPL | Replimune Group, Inc. | 1.21B | 3.05% | 1,123,730 | - |
| 146 | VSTM | Verastem, Inc. | 1.21B | -0.70% | 1,906,072 | 87.53M |
| 147 | SLN | Silence Therapeutics plc | 1.19B | -0.05% | 540,676 | 615.00K |
| 148 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 3.26% | 53,338 | - |
| 149 | BCAX | Bicara Therapeutics Inc. | 1.15B | 3.02% | 236,237 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.13B | -5.93% | 308,518 | - |
| 151 | VOR | Vor Biopharma Inc. | 1.11B | 2.13% | 260,229 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.06B | 3.59% | 275,097 | 24.00M |
| 153 | CTY | City Therapeutics, Inc. | 1.05B | 1.20% | 110,369 | 14.34M |
| 154 | MNKD | MannKind Corporation | 1.03B | -0.62% | 527,085 | 393.63M |
| 155 | SGP | SpyGlass Pharma, Inc. | 1.02B | 1.57% | 10,777 | - |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.01B | 0.68% | 317,133 | - |
| 157 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | -0.13% | 65,782 | - |
| 158 | IMTX | Immatics N.V. | 993.74M | 1.68% | 495,715 | 47.65M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 948.59M | 1.38% | 123,754 | - |
| 160 | JBIO | Jade Biosciences, Inc. | 948.24M | 2.83% | 168,563 | - |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 937.02M | 0.95% | 2,300,508 | - |
| 162 | RIGL | Rigel Pharmaceuticals, Inc. | 929.32M | -0.32% | 28,534 | 276.79M |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 919.08M | -0.62% | 62,290 | 99.00K |
| 164 | MGTX | MeiraGTx Holdings plc | 911.45M | 3.38% | 196,465 | 397.50M |
| 165 | AKTS | Aktis Oncology, Inc. | 909.66M | 3.97% | 91,360 | 10.06M |
| 166 | ANRO | Alto Neuroscience, Inc. | 909.24M | 4.79% | 150,910 | - |
| 167 | GLUE | Monte Rosa Therapeutics, Inc. | 902.62M | 0.95% | 583,722 | 28.73M |
| 168 | IVA | Inventiva S.A. | 896.67M | 0.55% | 965,729 | 2.81M |
| 169 | CRVS | Corvus Pharmaceuticals, Inc. | 888.32M | 1.05% | 371,831 | - |
| 170 | OBX | Obsidian Therapeutics, Inc. | 869.76M | 1.59% | 130,500 | - |
| 171 | KURA | Kura Oncology, Inc. | 860.25M | 0.52% | 533,710 | 77.23M |
| 172 | ABUS | Arbutus Biopharma Corporation | 844.81M | 1.67% | 500,446 | 181.72M |
| 173 | PHAR | Pharming Group N.V. | 834.27M | - | 13,976 | 386.75M |
| 174 | ALMS | Alumis Inc. | 828.39M | -1.69% | 879,655 | 7.40M |
| 175 | APMD | Apnimed, Inc. | 782.66M | -0.79% | 107,786 | 115.12M |
| 176 | HELP | Helus Pharma Inc. | 766.40M | 1.25% | 863,455 | - |
| 177 | AVBP | ArriVent BioPharma, Inc. | 747.51M | -1.30% | 393,586 | - |
| 178 | ARDX | Ardelyx, Inc. | 746.32M | -0.17% | 2,063,586 | 450.89M |
| 179 | GERN | Geron Corporation | 745.27M | 0.87% | 2,534,473 | 204.56M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 742.76M | 10.08% | 1,338,151 | 132.42M |
| 181 | SGMT | Sagimet Biosciences Inc. | 730.36M | 7.74% | 443,258 | - |
| 182 | PRME | Prime Medicine, Inc. | 727.63M | 13.30% | 4,065,903 | 4.07M |
| 183 | SANA | Sana Biotechnology, Inc. | 727.45M | 2.97% | 774,299 | - |
| 184 | ANNX | Annexon, Inc. | 712.82M | 1.62% | 884,484 | - |
| 185 | OABI | OmniAb, Inc. | 708.05M | 5.64% | 348,594 | 38.46M |
| 186 | ACHV | Achieve Life Sciences, Inc. | 696.65M | 3.52% | 704,754 | - |
| 187 | ANL | Adlai Nortye Group Ltd. | 696.14M | 2.17% | 21,698 | 18.06M |
| 188 | IAM | Iambic Therapeutics, Inc. | 688.73M | 0.83% | 200,684 | 18.25M |
| 189 | SLBT | SL Science Holding Limited | 684.32M | -2.44% | 9,071 | 3.27M |
| 190 | GYRE | Gyre Therapeutics, Inc. | 678.62M | 5.44% | 61,973 | 109.82M |
| 191 | IMMX | Immix Biopharma, Inc. | 658.66M | -1.43% | 453,102 | - |
| 192 | SLDB | Solid Biosciences Inc. | 657.29M | 5.51% | 613,336 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 656.31M | 1.72% | 809,562 | 41.47M |
| 194 | DSGN | Design Therapeutics, Inc. | 653.98M | 1.06% | 98,952 | - |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 652.43M | 7.07% | 434,724 | 92.01M |
| 196 | WVE | Wave Life Sciences, Inc. | 648.29M | 2.49% | 1,739,959 | 70.92M |
| 197 | ATTO | Attovia Therapeutics, Inc. | 645.97M | 1.95% | 136,563 | 1.80M |
| 198 | AURA | Aura Biosciences, Inc. | 639.86M | -0.16% | 188,781 | - |
| 199 | CADL | Candel Therapeutics, Inc. | 628.22M | 5.39% | 340,193 | - |
| 200 | CRMD | CorMedix Inc. | 623.55M | 0.76% | 366,813 | 462.25M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 617.73M | 6.65% | 658,058 | - |
| 202 | DBVT | DBV Technologies S.A. | 612.93M | 3.36% | 470,793 | 5.04M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 603.34M | 6.61% | 468,372 | 136.07M |
| 204 | NVCT | Nuvectis Pharma, Inc. | 600.80M | -0.27% | 57,710 | - |
| 205 | STTK | Shattuck Labs, Inc. | 576.59M | 3.70% | 164,420 | 1.00M |
| 206 | CBIO | Crescent Biopharma, Inc. | 571.39M | 4.62% | 55,902 | 11.88M |
| 207 | CLYM | Climb Bio, Inc. | 570.92M | 12.83% | 2,267,613 | - |
| 208 | PBYI | Puma Biotechnology, Inc. | 565.24M | 0.92% | 93,184 | 231.24M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 554.94M | -0.53% | 4,395,074 | 8.22M |
| 210 | MDXG | MiMedx Group, Inc. | 552.43M | -1.56% | 687,599 | 355.17M |
| 211 | ETRA | Electra Therapeutics, Inc. | 551.09M | 4.90% | 45,435 | - |
| 212 | DRUG | Bright Minds Biosciences Inc. | 540.06M | 5.28% | 29,026 | - |
| 213 | INDP | Indaptus Therapeutics, Inc. | 536.00M | 4.49% | 211,749 | - |
| 214 | VALN | Valneva SE | 526.31M | 2.59% | 14,239 | 163.30M |
| 215 | ENTX | Entera Bio Ltd. | 521.77M | 4.90% | 46,733 | 42.00K |
| 216 | BLSM | BlossomHill Therapeutics, Inc. | 518.41M | -0.49% | 33,394 | - |
| 217 | CTMX | CytomX Therapeutics, Inc. | 502.26M | 3.60% | 2,156,740 | 18.30M |
| 218 | SRZN | Surrozen, Inc. | 495.81M | 3.89% | 125,733 | 11.51M |
| 219 | NGNE | Neurogene Inc. | 493.28M | 4.72% | 194,933 | 925.00K |
| 220 | OCS | Oculis Holding AG | 493.24M | 0.38% | 55,612 | 1.45M |
| 221 | ARVN | Arvinas, Inc. | 490.40M | 2.60% | 309,945 | 316.70M |
| 222 | MNPR | Monopar Therapeutics Inc. | 484.42M | 2.31% | 62,032 | - |
| 223 | FTH | Faeth Therapeutics, Inc. | 480.89M | 10.58% | 271,302 | - |
| 224 | PHAT | Phathom Pharmaceuticals, Inc. | 465.46M | -1.35% | 735,238 | 239.66M |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 454.59M | -3.55% | 72,934 | - |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.89M | 0.88% | 213,447 | - |
| 227 | PRTA | Prothena Corporation plc | 443.55M | 2.86% | 134,630 | 54.53M |
| 228 | PROK | ProKidney Corp. | 441.39M | 7.35% | 469,822 | 818.00K |
| 229 | RGNX | REGENXBIO Inc. | 436.35M | 0.46% | 308,325 | 174.48M |
| 230 | OVID | Ovid Therapeutics Inc. | 435.51M | 3.48% | 521,573 | 1.58M |
| 231 | YDES | YD Bio Limited | 430.65M | 14.93% | 35,637 | 1.24M |
| 232 | RZLT | Rezolute, Inc. | 423.78M | 5.76% | 477,511 | - |
| 233 | ALLO | Allogene Therapeutics, Inc. | 421.50M | 0.83% | 7,332,949 | 4.64M |
| 234 | MPLT | MapLight Therapeutics, Inc. | 420.99M | -1.11% | 70,690 | - |
| 235 | ASMB | Assembly Biosciences, Inc. | 412.91M | 3.10% | 59,486 | 74.85M |
| 236 | AUTL | Autolus Therapeutics plc | 412.55M | 1.31% | 695,702 | 117.39M |
| 237 | AGMB | AgomAb Therapeutics NV | 404.82M | -4.08% | 26,234 | - |
| 238 | ALT | Altimmune, Inc. | 400.71M | 0.49% | 2,388,148 | 31.00K |
| 239 | CCCC | C4 Therapeutics, Inc. | 397.37M | 8.39% | 1,692,550 | 35.04M |
| 240 | ZURA | Zura Bio Limited | 397.21M | 16.43% | 2,369,070 | - |
| 241 | PRLD | Prelude Therapeutics Incorporated | 395.50M | 3.78% | 63,992 | 22.42M |
| 242 | TECX | Tectonic Therapeutic, Inc. | 394.90M | 1.25% | 57,576 | - |
| 243 | EDIT | Editas Medicine, Inc. | 392.40M | 6.46% | 1,139,497 | 47.01M |
| 244 | TRXB | TRex Bio, Inc. | 374.89M | 0.40% | 14,559 | - |
| 245 | SPRY | ARS Pharmaceuticals, Inc. | 369.45M | -5.23% | 537,502 | 116.93M |
| 246 | FENC | Fennec Pharmaceuticals Inc. | 365.40M | 2.66% | 20,233 | 59.22M |
| 247 | AVTX | Avalo Therapeutics, Inc. | 364.68M | 0.44% | 1,023,270 | 59.00K |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 356.35M | 1.96% | 115,518 | 65.26M |
| 249 | RLMD | Relmada Therapeutics, Inc. | 346.68M | 0.62% | 344,995 | - |
| 250 | CAPR | Capricor Therapeutics, Inc. | 341.28M | 2.26% | 1,055,128 | 11.13M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 339.52M | 4.17% | 395,615 | - |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 334.45M | 0.24% | 46,051 | - |
| 253 | OBIO | Orchestra BioMed Holdings, Inc. | 332.98M | -0.18% | 75,303 | 31.98M |
| 254 | GALT | Galectin Therapeutics Inc. | 331.80M | 3.13% | 70,493 | - |
| 255 | CTNM | Contineum Therapeutics, Inc. | 331.07M | 8.11% | 72,128 | - |
| 256 | NAUT | Nautilus Biotechnology, Inc. | 330.23M | 6.35% | 11,584,767 | 424.00K |
| 257 | VTVT | vTv Therapeutics Inc. | 326.15M | 1.70% | 6,511 | 36.84M |
| 258 | TTRX | Turn Therapeutics Inc. | 317.84M | 0.57% | 50,541 | - |
| 259 | ARCT | Arcturus Therapeutics Holdings Inc. | 310.66M | 10.29% | 327,392 | 29.37M |
| 260 | ALEC | Alector, Inc. | 309.86M | 14.21% | 1,846,404 | 13.86M |
| 261 | EIKN | Eikon Therapeutics, Inc. | 307.12M | 2.35% | 276,398 | - |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 305.37M | -5.23% | 979,506 | 15.85M |
| 263 | BNTC | Benitec Biopharma Inc. | 304.53M | 1.63% | 45,080 | - |
| 264 | VOGX | Vogenx, Inc. | 296.95M | 15.28% | 42,902 | - |
| 265 | SCTX | Scribe Therapeutics Inc. | 295.33M | - | 376,296 | 33.30M |
| 266 | IRD | Opus Genetics, Inc. | 287.86M | 4.22% | 460,468 | 9.86M |
| 267 | IKT | Inhibikase Therapeutics, Inc. | 284.95M | 2.96% | 496,115 | 1.00 |
| 268 | AGEN | Agenus Inc. | 283.18M | 2.11% | 343,358 | 132.69M |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 278.48M | 0.27% | 428,888 | 80.00M |
| 270 | SABS | SAB Biotherapeutics, Inc. | 276.60M | 8.96% | 245,620 | 114.70K |
| 271 | VCRE | Vicore Pharma Holding AB (publ) | 270.01M | 2.45% | 20,849 | 412.09K |
| 272 | RCKT | Rocket Pharmaceuticals, Inc. | 268.95M | 7.46% | 778,404 | - |
| 273 | IPSC | Century Therapeutics, Inc. | 266.18M | 3.52% | 190,822 | 109.16M |
| 274 | BCYC | Bicycle Therapeutics plc | 262.47M | 2.74% | 267,069 | 61.21M |
| 275 | QTTB | Q32 Bio Inc. | 258.10M | 2.60% | 154,968 | 53.74M |
| 276 | OCGN | Ocugen, Inc. | 258.06M | 7.43% | 3,936,694 | 4.58M |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 257.97M | 2.32% | 424,235 | 13.08M |
| 278 | ABEO | Abeona Therapeutics Inc. | 254.18M | 3.13% | 244,756 | 25.52M |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 252.76M | -0.81% | 1,248 | 65.05M |
| 280 | IMRX | Immuneering Corporation | 248.11M | 3.37% | 234,794 | - |
| 281 | FATE | Fate Therapeutics, Inc. | 247.43M | 0.49% | 432,856 | 6.49M |
| 282 | GLSI | Greenwich LifeSciences, Inc. | 245.86M | -2.19% | 105,645 | - |
| 283 | IFRX | InflaRx N.V. | 243.16M | 4.76% | 240,249 | -11.54K |
| 284 | LYEL | Lyell Immunopharma, Inc. | 241.99M | 6.07% | 16,863 | 27.00K |
| 285 | LRMR | Larimar Therapeutics, Inc. | 239.04M | 2.23% | 464,724 | - |
| 286 | CABA | Cabaletta Bio, Inc. | 237.36M | 3.70% | 2,711,840 | - |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 235.20M | -1.27% | 979,924 | 215.72M |
| 288 | SLGL | Sol-Gel Technologies Ltd. | 229.28M | 0.57% | 18,772 | 1.80M |
| 289 | KROS | Keros Therapeutics, Inc. | 228.81M | 1.85% | 35,225 | 15.01M |
| 290 | LXEO | Lexeo Therapeutics, Inc. | 227.67M | 2.78% | 832,209 | - |
| 291 | CAMP | Camp4 Therapeutics Corporation | 223.09M | 10.75% | 43,747 | 4.22M |
| 292 | PALI | Palisade Bio, Inc. | 214.35M | - | 1,436,506 | 500.00K |
| 293 | ACIU | AC Immune SA | 210.79M | -8.23% | 345,553 | 21.67M |
| 294 | PYXS | Pyxis Oncology, Inc. | 210.24M | 4.14% | 424,665 | 11.04M |
| 295 | ARTV | Artiva Biotherapeutics, Inc. | 208.76M | -30.68% | 5,938,483 | 251.00K |
| 296 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 206.05M | -2.65% | 147,258 | - |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 201.43M | 0.81% | 109,317 | 80.62M |
| 298 | KRRO | Korro Bio, Inc. | 199.24M | 12.56% | 181,203 | 2.38M |
| 299 | ZNTL | Zentalis Pharmaceuticals, Inc. | 198.34M | 1.21% | 433,122 | 26.87M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 194.84M | 2.55% | 44,295 | 1.48M |
| 301 | ACOG | Alpha Cognition Inc. | 191.86M | 6.14% | 76,750 | 15.26M |
| 302 | ELDN | Eledon Pharmaceuticals, Inc. | 189.53M | 5.43% | 294,152 | - |
| 303 | EVMN | Evommune, Inc. | 189.08M | 1.56% | 565,761 | 10.00M |
| 304 | YARW | Yarrow Bioscience, Inc. | 185.67M | -0.23% | 80,880 | - |
| 305 | PRQR | ProQR Therapeutics N.V. | 184.87M | 5.65% | 1,177,533 | 21.05M |
| 306 | CGEN | Compugen Ltd. | 183.76M | 3.47% | 48,920 | 74.00M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 183.57M | 2.55% | 78,318 | 7.15M |
| 308 | DTIL | Precision BioSciences, Inc. | 182.17M | 2.96% | 43,709 | 45.06M |
| 309 | PEPG | PepGen Inc. | 177.30M | 2.81% | 427,649 | - |
| 310 | IVVD | Invivyd, Inc. | 174.29M | 0.36% | 2,145,581 | 58.37M |
| 311 | SION | Sionna Therapeutics, Inc. | 174.07M | 4.34% | 434,990 | - |
| 312 | ADAG | Adagene Inc. | 173.23M | 3.61% | 59,222 | 9.29M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 171.80M | 1.23% | 26,427 | 2.00M |
| 314 | TRDA | Entrada Therapeutics, Inc. | 166.94M | -2.53% | 81,243 | 4.69M |
| 315 | NGEN | NervGen Pharma Corp. | 164.51M | 7.75% | 224,172 | - |
| 316 | CHRS | Coherus Oncology, Inc. | 162.23M | 3.96% | 243,012 | 50.94M |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 158.40M | -3.52% | 907,899 | - |
| 318 | MDWD | MediWound Ltd. | 158.34M | 1.66% | 26,045 | 11.86M |
| 319 | ALXO | ALX Oncology Holdings Inc. | 156.25M | - | 514,491 | - |
| 320 | UPB | Upstream Bio, Inc. | 154.18M | 2.36% | 440,396 | 3.16M |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 151.39M | 4.40% | 302,235 | 1.50M |
| 322 | STRO | Sutro Biopharma, Inc. | 149.81M | 1.69% | 157,443 | 45.70M |
| 323 | MGNX | MacroGenics, Inc. | 149.06M | 6.85% | 1,212,414 | 175.14M |
| 324 | MSLE | Satellos Bioscience Inc. | 148.65M | 5.28% | 17,000 | - |
| 325 | MOLN | Molecular Partners AG | 148.41M | 1.11% | 1,158 | 856.30K |
| 326 | NBP | NovaBridge Biosciences | 146.16M | 3.70% | 331,020 | - |
| 327 | VRXA | Veraxa Biotech AG | 142.82M | 3.06% | 33,030 | 29.54K |
| 328 | TARA | Protara Therapeutics, Inc. | 142.42M | 2.55% | 856,157 | - |
| 329 | CDXS | Codexis, Inc. | 141.81M | -0.38% | 129,041 | 77.68M |
| 330 | RNA | Atrium Therapeutics, Inc. | 141.72M | 2.92% | 62,088 | 35.84M |
| 331 | ANTX | AN2 Therapeutics, Inc. | 140.38M | 2.48% | 102,444 | - |
| 332 | MENS | Jyong Biotech Ltd. | 138.07M | 5.08% | 9,309 | - |
| 333 | IPHA | Innate Pharma S.A. | 137.37M | 0.68% | 1,093 | 11.21M |
| 334 | CMPX | Compass Therapeutics, Inc. | 136.76M | 1.63% | 557,690 | 850.00K |
| 335 | SPRB | Spruce Biosciences, Inc. | 134.56M | 6.43% | 44,532 | 697.00K |
| 336 | CUE | Cue Biopharma, Inc. | 131.92M | -1.57% | 27,554 | 37.66M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 131.62M | 2.61% | 20,137 | 5.54M |
| 338 | OTLK | Outlook Therapeutics, Inc. | 128.95M | 3.20% | 1,706,573 | -1.16M |
| 339 | HURA | TuHURA Biosciences, Inc. | 128.73M | -0.98% | 272,607 | - |
| 340 | HUMA | Humacyte, Inc. | 128.54M | 15.50% | 1,886,042 | 2.12M |
| 341 | FHTX | Foghorn Therapeutics Inc. | 121.15M | -0.49% | 343,269 | 36.74M |
| 342 | AVXL | Anavex Life Sciences Corp. | 118.19M | -0.39% | 564,048 | - |
| 343 | RTSN | Retension Pharmaceuticals, Inc. | 117.31M | -1.12% | 48,107 | - |
| 344 | NKTX | Nkarta, Inc. | 115.67M | -11.75% | 1,471,018 | - |
| 345 | TLSA | Tiziana Life Sciences Ltd | 115.49M | 2.24% | 53,170 | - |
| 346 | PYPD | PolyPid Ltd. | 115.17M | 7.18% | 121,459 | - |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 114.86M | 4.12% | 370,177 | 3.39M |
| 348 | KZIA | Kazia Therapeutics Limited | 113.33M | 5.08% | 83,893 | 1.27M |
| 349 | ANIX | Anixa Biosciences, Inc. | 110.55M | 8.53% | 165,498 | - |
| 350 | OKUR | OnKure Therapeutics, Inc. | 109.54M | 9.29% | 65,659 | - |
| 351 | SEER | Seer, Inc. | 109.08M | 2.07% | 68,560 | 14.22M |
| 352 | VYGR | Voyager Therapeutics, Inc. | 109.06M | 1.14% | 493,259 | 34.46M |
| 353 | CBUS | Cibus, Inc. | 107.00M | 0.36% | 28,137 | 4.35M |
| 354 | NERV | Minerva Neurosciences, Inc. | 106.72M | 1.59% | 82,704 | - |
| 355 | ENGN | enGene Therapeutics Inc. | 105.55M | -0.32% | 131,140 | - |
| 356 | VANI | Vivani Medical, Inc. | 104.64M | 2.65% | 71,435 | - |
| 357 | IMUX | Immunic, Inc. | 101.51M | 2.20% | 162,816 | - |
| 358 | TVGN | Tevogen Inc. | 101.50M | 3.20% | 651 | - |
| 359 | UNCY | Unicycive Therapeutics, Inc. | 99.72M | - | 423,660 | - |
| 360 | LENZ | LENZ Therapeutics, Inc. | 99.29M | 0.48% | 176,960 | 21.48M |
| 361 | COYA | Coya Therapeutics, Inc. | 98.99M | 6.84% | 24,853 | 8.02M |
| 362 | TENX | Tenax Therapeutics, Inc. | 97.95M | 4.27% | 619,316 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 96.52M | -0.59% | 327,687 | 70.00M |
| 364 | PLYX | Polaryx Therapeutics, Inc. | 95.70M | 5.49% | 8,463 | - |
| 365 | MIST | Milestone Pharmaceuticals Inc. | 95.62M | 5.31% | 434,833 | 2.34M |
| 366 | TNYA | Tenaya Therapeutics, Inc. | 95.41M | 4.14% | 706,596 | 1.34M |
| 367 | NRXS | NeurAxis, Inc. | 94.18M | 3.45% | 34,037 | 5.32M |
| 368 | PMVP | PMV Pharmaceuticals, Inc. | 93.64M | 9.73% | 217,121 | - |
| 369 | ICCC | ImmuCell Corporation | 93.09M | 0.10% | 940 | 30.68M |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 91.91M | 2.20% | 2,111,074 | 65.34K |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 90.90M | - | 388,613 | 29.10M |
| 372 | PDSB | PDS Biotechnology Corporation | 89.14M | 15.49% | 5,236,215 | - |
| 373 | GNLX | Genelux Corporation | 87.16M | 1.83% | 718,284 | 8.00K |
| 374 | EQ | Equillium, Inc. | 86.87M | 9.60% | 160,711 | 4.39M |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 86.83M | 3.59% | 5,114 | 6.19M |
| 376 | RLYB | Rallybio Corporation | 85.23M | -3.60% | 16,627 | 646.00K |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 84.21M | -2.12% | 185,475 | 4.88M |
| 378 | CNXU | Conexeu Sciences Inc. | 83.21M | 0.34% | 130,413 | - |
| 379 | PMN | ProMIS Neurosciences, Inc. | 82.55M | 14.21% | 11,323 | - |
| 380 | CLLS | Cellectis S.A. | 80.47M | 5.46% | 65,592 | 63.82M |
| 381 | CING | Cingulate Inc. | 79.69M | 5.79% | 172,608 | - |
| 382 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 78.72M | 2.01% | 206,460 | - |
| 383 | TELO | Telomir Pharmaceuticals, Inc. | 78.22M | 6.41% | 35,806 | - |
| 384 | OKYO | OKYO Pharma Limited | 76.10M | 0.69% | 7,530 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 75.85M | 2.91% | 90,584 | - |
| 386 | NTHI | NeOnc Technologies Holdings, Inc. | 73.95M | 5.50% | 32,873 | 39.99K |
| 387 | NTRB | Nutriband Inc. | 72.63M | 0.08% | 667 | 1.62M |
| 388 | NMRA | Neumora Therapeutics, Inc. | 72.49M | -1.81% | 678,119 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 71.17M | 5.41% | 119,473 | - |
| 390 | CGTX | Cognition Therapeutics, Inc. | 70.51M | 6.71% | 153,031 | - |
| 391 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 24,336 | 920.48K |
| 392 | CSBR | Champions Oncology, Inc. | 68.06M | 0.62% | 2,657 | 60.66M |
| 393 | CRDF | Cardiff Oncology, Inc. | 67.94M | 8.58% | 233,693 | 508.00K |
| 394 | FBIO | Fortress Biotech, Inc. | 65.03M | 4.28% | 80,235 | 68.47M |
| 395 | SPRO | Spero Therapeutics, Inc. | 64.06M | 2.80% | 294,153 | 47.00M |
| 396 | RNXT | RenovoRx, Inc. | 61.38M | 3.82% | 72,931 | 1.98M |
| 397 | ONCY | Oncolytics Biotech Inc. | 60.63M | 0.49% | 578,945 | - |
| 398 | HRTX | Heron Therapeutics, Inc. | 59.72M | 4.61% | 391,111 | 151.18M |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 59.01M | 0.44% | 16,013 | 30.32M |
| 400 | RNTX | Rein Therapeutics Inc. | 58.99M | 17.25% | 456,628 | - |
| 401 | GOSS | Gossamer Bio, Inc. | 58.63M | 4.75% | 48,135 | 53.29M |
| 402 | CLNN | Clene Inc. | 57.42M | 5.21% | 11,119 | 197.00K |
| 403 | PTHS | Pelthos Therapeutics Inc. | 57.39M | -1.38% | 28,918 | 43.30M |
| 404 | OSTX | OS Therapies Incorporated | 57.29M | 2.48% | 178,046 | - |
| 405 | XBIT | XBiotech Inc. | 56.40M | - | 27,161 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 55.11M | 3.55% | 4,577 | - |
| 407 | HYFT | MindWalk Holdings Corp. | 54.89M | 1.30% | 33,660 | 11.57M |
| 408 | BOLD | Boundless Bio, Inc. | 54.59M | -0.41% | 45,071 | - |
| 409 | ALPS | Alps Group Inc | 54.06M | -0.82% | 30,176 | 3.74M |
| 410 | PLRX | Pliant Therapeutics, Inc. | 53.82M | 2.28% | 106,151 | - |
| 411 | GANX | Gain Therapeutics, Inc. | 52.15M | 3.91% | 212,928 | - |
| 412 | CNTB | Connect Biopharma Holdings Limited | 52.08M | -2.58% | 118,685 | 2.95M |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.38M | -3.34% | 2,836 | - |
| 414 | CRBU | Caribou Biosciences, Inc. | 50.84M | -3.65% | 549,875 | 10.04M |
| 415 | HOWL | Werewolf Therapeutics, Inc. | 50.06M | 5.04% | 123,777 | 21.00M |
| 416 | IBIO | iBio, Inc. | 48.87M | 7.50% | 200,707 | 100.00K |
| 417 | XLO | Xilio Therapeutics, Inc. | 48.10M | - | 5,671 | 64.09M |
| 418 | BMEA | Biomea Fusion, Inc. | 47.11M | 2.25% | 462,625 | - |
| 419 | MREO | Mereo BioPharma Group plc | 46.79M | 6.55% | 218,592 | 500.00K |
| 420 | LONA | LeonaBio, Inc. | 46.64M | 3.99% | 87,241 | - |
| 421 | IMA | ImageneBio, Inc. | 46.31M | 0.74% | 1,788 | 800.00K |
| 422 | HYPD | Hyperion DeFi, Inc. | 45.84M | 3.51% | 54,279 | 1.40M |
| 423 | ATNM | Actinium Pharmaceuticals, Inc. | 45.14M | 2.56% | 60,142 | 35.09M |
| 424 | ELTX | Elicio Therapeutics, Inc. | 44.02M | -1.47% | 139,148 | - |
| 425 | KLRS | Kalaris Therapeutics, Inc. | 43.09M | 0.56% | 5,350 | - |
| 426 | APLM | Apollomics, Inc. | 42.56M | -2.61% | 171 | 8.84M |
| 427 | ANVS | Annovis Bio, Inc. | 42.38M | 3.95% | 406,507 | - |
| 428 | ACET | Adicet Bio, Inc. | 42.03M | -0.89% | 87,587 | - |
| 429 | INMB | INmune Bio Inc. | 41.77M | 5.24% | 192,709 | 50.00K |
| 430 | TIL | Instil Bio, Inc. | 40.76M | 7.90% | 36,239 | - |
| 431 | GRCE | Grace Therapeutics, Inc. | 39.97M | 4.97% | 42,985 | - |
| 432 | ALDX | Aldeyra Therapeutics, Inc. | 39.51M | 2.07% | 416,077 | - |
| 433 | GRDX | GridAI Technologies Corp. | 39.12M | -0.45% | 63,438 | - |
| 434 | ATHE | Alterity Therapeutics Limited | 38.96M | 0.96% | 1,221 | 2.50M |
| 435 | VERU | Veru Inc. | 38.15M | 1.24% | 74,338 | 16.89M |
| 436 | DWTX | Dogwood Therapeutics, Inc. | 38.07M | 0.90% | 8,223 | - |
| 437 | SER | Serina Therapeutics, Inc. | 37.85M | -12.87% | 100,800 | 130.00K |
| 438 | ESLA | Estrella Immunopharma, Inc. | 37.84M | -5.32% | 489,617 | - |
| 439 | NNVC | NanoViricides, Inc. | 37.27M | 7.35% | 155,807 | - |
| 440 | LITS | Lite Strategy, Inc. | 35.27M | 3.57% | 39,778 | - |
| 441 | EDSA | Edesa Biotech, Inc. | 34.99M | - | 8,946 | - |
| 442 | EXOZ | eXoZymes, Inc. | 34.62M | -0.53% | 15,446 | -700.00 |
| 443 | CRVO | CervoMed Inc. | 34.02M | 0.45% | 99,539 | 331.30K |
| 444 | IRLA | IRulya Therapeutics Inc. | 32.71M | 2.50% | 25,267 | - |
| 445 | MGX | Metagenomi Therapeutics, Inc. | 32.49M | 12.07% | 127,891 | 13.56M |
| 446 | IBO | Impact BioMedical Inc. | 31.95M | 0.27% | 9,545 | 35.00K |
| 447 | BCTX | BriaCell Therapeutics Corp. | 31.43M | 4.00% | 42,019 | - |
| 448 | EYPT | EyePoint, Inc. | 31.41M | -0.38% | 5,242,656 | 2.79M |
| 449 | FLNA | Filana Therapeutics, Inc. | 30.68M | 3.81% | 170,962 | - |
| 450 | ALGS | Aligos Therapeutics, Inc. | 29.60M | 1.94% | 5,949 | 31.52M |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 29.11M | 0.82% | 4,947 | - |
| 452 | AARD | Aardvark Therapeutics, Inc. | 27.79M | 17.59% | 3,432,318 | - |
| 453 | BSEM | BioStem Technologies, Inc. | 27.69M | -3.25% | 173,546 | 34.59M |
| 454 | CELU | Celularity Inc. | 27.56M | 13.23% | 158,732 | 18.67M |
| 455 | ABVC | ABVC BioPharma, Inc. | 27.00M | -0.95% | 12,453 | 797.92K |
| 456 | CVM | CEL-SCI Corporation | 26.56M | -5.03% | 87,191 | - |
| 457 | IGC | IGC Pharma, Inc. | 25.83M | -0.04% | 56,604 | 1.11M |
| 458 | EVAX | Evaxion A/S | 25.44M | -0.97% | 48,428 | 7.49M |
| 459 | NXTC | NextCure, Inc. | 25.27M | 5.65% | 112,573 | - |
| 460 | ATOS | Atossa Therapeutics, Inc. | 24.85M | 1.63% | 7,867 | - |
| 461 | IMMP | Immutep Limited | 23.19M | 1.94% | 7,850 | 13.79M |
| 462 | CNTX | Context Therapeutics Inc. | 21.91M | -0.58% | 367,465 | - |
| 463 | PLRZ | Polyrizon Ltd. | 20.91M | -3.88% | 3,241 | - |
| 464 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.65M | 2.00% | 649 | - |
| 465 | BYSI | BeyondSpring Inc. | 19.09M | 0.91% | 10,799 | 1.88M |
| 466 | AKTX | Akari Therapeutics, Plc | 19.01M | 9.04% | 32,997 | - |
| 467 | COCP | Cocrystal Pharma, Inc. | 18.83M | 0.58% | 11,566 | 330.00K |
| 468 | QNTM | Quantum BioPharma Ltd. | 18.46M | -1.36% | 45,602 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.29M | - | 363 | 1.17M |
| 470 | MCRB | Seres Therapeutics, Inc. | 18.23M | -8.33% | 128,947 | 1.88M |
| 471 | KYNB | Kyntra Bio, Inc. | 18.18M | -0.22% | 3,712 | 4.62M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 16.57M | -1.44% | 324,515 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 16.33M | 8.05% | 74,012 | 3.55M |
| 474 | NCEL | NewcelX Ltd. | 15.28M | 3.73% | 3,672 | - |
| 475 | PLUR | Pluri Inc. | 15.18M | 9.78% | 97,192 | 1.02M |
| 476 | DYAI | Dyadic International, Inc. | 14.94M | -1.44% | 48,679 | 3.80M |
| 477 | KPRX | Kiora Pharmaceuticals, Inc. | 14.44M | 2.71% | 3,873 | 20.00K |
| 478 | ALLR | Allarity Therapeutics, Inc. | 14.43M | -0.87% | 92,921 | 345.00K |
| 479 | BCDA | BioCardia, Inc. | 14.02M | 2.71% | 27,156 | 3.00K |
| 480 | TCRX | TScan Therapeutics, Inc. | 13.27M | 3.22% | 218,284 | 7.11M |
| 481 | GUTS | Fractyl Health, Inc. | 13.09M | -7.76% | 318,622 | 3.00K |
| 482 | ICU | SeaStar Medical Holding Corporation | 13.05M | 0.40% | 24,349 | 1.71M |
| 483 | DARE | Daré Bioscience, Inc. | 12.90M | 1.86% | 16,278 | 1.37M |
| 484 | CNSY | Cerenome, Inc. | 12.83M | 7.64% | 13,708 | 4.20M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 12.70M | -4.95% | 238,024 | - |
| 486 | AEON | AEON Biopharma, Inc. | 12.70M | 6.04% | 58,318 | - |
| 487 | BOLT | Bolt Biotherapeutics, Inc. | 12.25M | -3.49% | 124,511 | 4.70M |
| 488 | HIND | Vyome Holdings, Inc. | 12.09M | 0.74% | 1,803 | 129.73K |
| 489 | LPCN | Lipocine Inc. | 12.00M | 0.34% | 57,842 | 1.57M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 11.98M | -2.89% | 125,941 | 7.11M |
| 491 | PBM | Psyence Biomedical Ltd. | 11.82M | -15.30% | 189,908 | - |
| 492 | CLRB | Cellectar Biosciences, Inc. | 11.82M | 3.31% | 109,653 | - |
| 493 | TVRD | Tvardi Therapeutics, Inc. | 11.57M | 2.96% | 29,006 | - |
| 494 | RADX | Radiopharm Theranostics Limited | 11.37M | -6.63% | 13,980 | 8.90M |
| 495 | GDTC | CytoMed Therapeutics Limited | 11.16M | 0.95% | 1,563 | 609.73K |
| 496 | ATYR | aTyr Pharma, Inc. | 11.11M | -26.14% | 5,757,159 | 190.00K |
| 497 | BIVI | BioVie Inc. | 10.94M | 9.02% | 118,452 | - |
| 498 | PASG | Passage Bio, Inc. | 10.84M | 0.33% | 649 | - |
| 499 | ADIL | Adial Pharmaceuticals, Inc. | 10.57M | 9.38% | 4,014 | - |
| 500 | PPBT | Purple Biotech Ltd | 10.28M | -1.97% | 10,953 | - |